Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties

Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties

US Patent 11752215 · Granted Sep 12, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of multi-frequency impedance cytometry in conjunction with machine learning 2023
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Markers for abnormal cells2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Intestinal peptide targeting ligands2017